This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Edward Chouchani: Innovator in Cancer Treatment
Introduction
Edward Chouchani is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds.
Latest Patents
Chouchani holds a patent for "Covalent inhibitors of creatine kinase (CK) and uses thereof for treating and preventing cancer." This patent focuses on compounds that inhibit creatine kinase, which are crucial in developing methods for treating various forms of cancer, including hematological malignancies. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Edward Chouchani is affiliated with the Dana-Farber Cancer Institute Inc., where he conducts his research. His work is pivotal in exploring new therapeutic avenues for cancer treatment, emphasizing the importance of creatine kinase inhibitors.
Collaborations
Chouchani collaborates with Tinghu Zhang, further enhancing the research efforts at the Dana-Farber Cancer Institute Inc. Their partnership exemplifies the collaborative spirit necessary for groundbreaking discoveries in cancer research.
Conclusion
Edward Chouchani's innovative work in developing covalent inhibitors of creatine kinase represents a significant advancement in cancer treatment. His contributions are vital in the ongoing fight against cancer, and his research continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile